| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/22/2011 | US7893102 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses |
| 02/22/2011 | US7893094 Amphiphilic pyridinium compounds, method of making and use thereof |
| 02/22/2011 | US7893041 Oligosaccharide compositions and use thereof in the treatment of infection |
| 02/22/2011 | US7893021 Parathyroid hormone antagonists and uses thereof |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | US7892522 Administering contrast-enhancing amount of a contrast agent comprising microbubbles of biocompatible gas stabilised by opsonisable amphiphilic material, allowing liver to take up; generating ultrasound image of liver |
| 02/22/2011 | CA2540678C Pharmaceutical compositions for prevention of overdose or abuse |
| 02/22/2011 | CA2534234C Sterile preparations of phospholipids and anti-inflammatory pharmaceuticals and methods for making and using same |
| 02/17/2011 | US20110039910 Modulation of apolipoprotein (a) expression |
| 02/17/2011 | US20110039802 Npy y5 antagonist |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/16/2011 | EP2283816A1 Melt-extruded orally administrable opioid formulations |
| 02/15/2011 | US7888328 Oral formulations of cladribine |
| 02/15/2011 | US7888312 Method of treating periodontal diseases by administering a therapeutically effective amount of GM-CSF |
| 02/15/2011 | US7887842 Methods of administering a dermatological agent to a subject |
| 02/15/2011 | US7887831 comprising synthetic apatite and supplementary bioactive agent such as biocompatible polysaccharide and anti-resorptive agent added ab initio; for treating orthopedic, periodontal and craniofacial indications |
| 02/15/2011 | US7887814 binding proteins, fused with transferrins; for treatment of Alzheimer's, Down Syndrome, infant encephalitis, AIDS, and autoimmune diseases |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | CA2689052C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/15/2011 | CA2455453C Taxol enhancer compounds |
| 02/10/2011 | US20110034379 Gastrin Compositions And Formulations, And Methods Of Use And Preparation |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/09/2011 | EP1638910B1 Color stabilization of hydroquinone hydroxyethyl ether products |
| 02/09/2011 | CN1889950B The use of urocanic acid being able to acidify the cell cytoplasm and for preventing or halting cellular proliferation in a person |
| 02/09/2011 | CN101966183A Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
| 02/09/2011 | CN101965974A Compositions and products containing enantiomeric equol, and methods for their making |
| 02/08/2011 | US7884554 Ignition circuit for igniting a discharge lamp and method for igniting the discharge lamp |
| 02/08/2011 | US7884113 Eating and metabolism disorders; obesity; metabolism disorders; central nervous system disorders; analgesics; antiinflammatory agents; cognition activators |
| 02/08/2011 | US7884097 Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| 02/08/2011 | US7883843 Using primate hepadnavirus loop region polypeptide sequences as tool in developing vaccine to prevent and treat viral infection |
| 02/08/2011 | US7883718 Methods and devices for the sustained release of multiple drugs |
| 02/08/2011 | US7883703 Methods of modulating immunity |
| 02/08/2011 | US7883691 Cosmetic composition comprising camel milk or components thereof |
| 02/08/2011 | CA2456604C Pharmaceutical composition comprising lumiracoxib |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2320419C Compositions comprising viruses and methods for concentrating virus preparations |
| 02/03/2011 | US20110028711 Unsaturated Steroid Compounds |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/02/2011 | EP2280082A2 Identification of surface-associated antigenes used for the diagnosis and therapy of tumours |
| 02/02/2011 | EP2280066A2 Recombinant Clostridium neurotoxin fragments |
| 02/02/2011 | EP2280014A2 Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B |
| 02/02/2011 | EP2279751A2 Stabilisation of macrolides |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | CN1767843B Method for preparing antimicrobial agent and antioxidant position from sea-buckthorn seeds |
| 02/01/2011 | US7879904 9, 10-α,α-OH-taxane analogs and methods for production thereof |
| 02/01/2011 | US7879901 Sublingual Formulations of Ketorolac or Salts Thereof |
| 02/01/2011 | US7879338 Expression vector comprising nucleotide sequences coding norwalk virus capsid protein for use in generating vaccine for prevention and treatment of gastrointestinal disorders |
| 02/01/2011 | CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 02/01/2011 | CA2543324C Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2454120C Taxol enhancer compounds |
| 01/27/2011 | US20110021525 P70S6 Kinase Modulators and Method of Use |
| 01/27/2011 | US20110020812 Methods of using fet labeled oligonucleotides that include a 3'-5' exonuclease resistant quencher domain and compositions for practicing the same |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277533A2 Methods for vaccinating against malaria |
| 01/26/2011 | EP2277532A1 Novel composition and methods for the treatment of immune related diseases |
| 01/26/2011 | EP2277527A2 Peptide YY analogs |
| 01/26/2011 | EP1660513B1 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 01/26/2011 | EP1615612B1 Pro-urokinase mutant for lysis of occlusive blood clots while sparing wound sealing clots in the treatment of stroke |
| 01/26/2011 | EP1603511B1 Treatment of igai deposition diseases |
| 01/26/2011 | CN1829521B Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | US7875594 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 01/25/2011 | US7875297 administering to the uterine cavity a plurality of physiologically inert beads bearing a tissue necrosing amount of silver nitrate as a solid silver ion source; |
| 01/25/2011 | CA2529965C Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 01/25/2011 | CA2483928C Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith |
| 01/25/2011 | CA2469594C Crystal of bicalutamide and production method thereof |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2405030C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/25/2011 | CA2368849C Process for preparing amine platinum complexes |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110015248 Substituted heterocycles |
| 01/20/2011 | US20110015228 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/20/2011 | US20110015145 Cladribine formulations for improved oral and transmucosal delivery |
| 01/20/2011 | US20110014628 Identification of Surface-Associated Antigens for Tumor Diagnosis and Therapy |
| 01/19/2011 | EP2275572A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275571A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275570A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP1670450B1 Pharmaceutical compositions and method of using levodopa and carbidopa |
| 01/19/2011 | EP1542660B1 Sustained released delivery of amphetamine salts |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101362731B Heterocyclic compounds and methods of use |
| 01/18/2011 | US7872014 Anaplastic lymphoma kinase modulators and methods of use |
| 01/18/2011 | US7871772 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
| 01/18/2011 | US7871468 having a mean particle size of less than about 10 microns; closely bound microcrystalline cellulose and at least one hydrocolloid; foods, cosmetics, pharmaceuticals |
| 01/18/2011 | CA2519556C Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same |
| 01/18/2011 | CA2368637C Topical treatment or prevention of ocular infections |
| 01/13/2011 | US20110009346 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/13/2011 | US20110008840 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/12/2011 | EP2272970A1 High viscosity xanthan polymer preparations |
| 01/12/2011 | EP2272833A1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 01/12/2011 | EP2272533A1 Soluble FcyR fusion proteins and methods of use thereof |
| 01/12/2011 | EP2272516A2 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 01/12/2011 | EP2272503A2 Oral formulations of cladribine |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |